In early January, the Vietnamese government extended the validity of certain drug licenses. First, drugs and drug substances with market authorizations that expire this calendar year will be automatically extended until December 31, 2024. Second, drugs and drug substances with market authorizations that have been extended via a previous regulation that has not been extended yet, will also be extended until Dec 31, 2024. Extensions are not possible for drugs that have been recalled, are unsafe, etc. The Vietnamese Ministry of Health has made these extensions due to the outbreak of COVID in Vietnam. Specific drugs and drug substances whose marketing authorizations will be extended will be announced soon.
Written by: Ames Gross – President and Founder, Pacific Bridge Medical (PBM)
Mr. Gross founded PBM in 1988 and has helped hundreds of medical companies with regulatory and business development issues in Asia. He is recognized nationally and internationally as a leader in the Asian medical markets. Mr. Gross has a BA degree, Phi Beta Kappa, from the University of Pennsylvania and an MBA from Columbia University.